Adam Crowe
Company: Precision NanoSystems
Job title: Manager, Analytical Development
Seminars:
Analytical Insights Supporting the Development of a CoVID-19 saRNA LNP Vaccine 2:30 pm
• Precision NanoSystems Inc.’s (PNI) self-amplifying RNA (saRNA) offers numerous advantages over smaller mRNA payloads in SARS CoV2 LNP vaccines due to its low therapeutic dose and prolonged antigen expression in vivo; however, its size (>9000 nt) poses unique analytical challenges requiring innovation • Assessment of saRNA quality attributes including integrity, 5’ cap structure, and…Read more
day: Day One